Cargando…
Current modalities of sickle cell disease management
Sickle cell disease (SCD) affects nearly 100,000 people in the United States of America and the sickle gene is present in approximately 8% of black Americans. Among Africans, the prevalence of sickle cell trait (heterozygosity) is as high as 30%. While SCD occurs among varying racial and ethnic grou...
Autores principales: | Sanyaolu, Adekunle, Agiri, Ejoke, Bertram, Carl, Brookes, Latasha, Choudhury, Jesy, Datt, Dorina, Ibrahim, Amira, Maciejko, Anna, Mansfield, Anna, Nkrumah, Jasmine, Williams, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974986/ https://www.ncbi.nlm.nih.gov/pubmed/35400022 http://dx.doi.org/10.1097/BS9.0000000000000056 |
Ejemplares similares
-
A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers
por: Lee, LaTasha H., et al.
Publicado: (2021) -
SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
por: Sanyaolu, Adekunle, et al.
Publicado: (2022) -
What's New in the Pathophysiology of Sickle Cell Disease?
por: Adekile, Adekunle D.
Publicado: (2013) -
Global Pandemicity of COVID-19: Situation Report as of June 9, 2020
por: Sanyaolu, Adekunle, et al.
Publicado: (2021) -
Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)